Insider Transactions last 24 months for Theravance Biopharma, Inc.  -  NSDQ: TBPH

 
Transactions
All Buy Sell Option Exercise
Filer's Name
Relationship/
Title
Trans.
Date
Trans. Type
Ownership Type
Security Type
Shares
Price
Trans.
Value
Total Shares Owned
Farnum RhondaSVP, COMM & MEDICAL AFFAIRS08/20/2025DFDirectCOM9,096$13.39$121,795.44317,822
Grimaud Brett A.SVP, GEN COUNSEL AND SECRETARY08/20/2025DFDirectCOM9,762$13.39$130,713.18374,306
Miller AineSVP, DEV & HEAD OF IRE OFFICE08/20/2025DFDirectCOM6,989$13.39$93,582.71208,001
Sawaf AzizSVP & CHIEF FINANCIAL OFFICER08/20/2025DFDirectCOM9,368$13.39$125,437.52355,422
Winningham Rick ECHIEF EXECUTIVE OFFICER08/20/2025DFDirectCOM15,394$13.39$206,125.661,717,786
Farnum RhondaSVP, COMM & MEDICAL AFFAIRS07/14/2025DSDirectCOM4,000$11.39$45,551.60326,918
Farnum RhondaSVP, COMM & MEDICAL AFFAIRS07/14/2025DSDirectCOM5,318$11.39$60,548.09330,918
Farnum RhondaSVP, COMM & MEDICAL AFFAIRS07/14/2025DSDirectCOM682$11.39$7,769.82336,236
Winningham Rick ECHIEF EXECUTIVE OFFICER06/23/2025DGDirectCOM20,000$0.00$0.001,733,180
Winningham Rick ECHIEF EXECUTIVE OFFICER06/13/2025AGIndirectCOM9,600$0.00$0.0013,500
Winningham Rick ECHIEF EXECUTIVE OFFICER06/13/2025DGDirectCOM9,600$0.00$0.001,753,180
Farnum RhondaSVP, COMM & MEDICAL AFFAIRS06/02/2025DSDirectCOM24,000$11.00$264,000.00336,918
Miller AineSVP, DEV & HEAD OF IRE OFFICE05/20/2025DFDirectCOM9,701$9.45$91,674.45214,990
Farnum RhondaSVP, COMM & MEDICAL AFFAIRS05/20/2025DFDirectCOM9,120$9.45$86,184.00360,918
Grimaud Brett A.SVP, GEN COUNSEL AND SECRETARY05/20/2025DFDirectCOM9,743$9.45$92,071.35384,068
Sawaf AzizSVP & CHIEF FINANCIAL OFFICER05/20/2025DFDirectCOM9,348$9.45$88,338.60364,790
Winningham Rick ECHIEF EXECUTIVE OFFICER05/20/2025DFDirectCOM15,364$9.45$145,189.801,762,780
Smaldone Alsup LaurieDirector05/19/2025AADirectCOM10,649$0.00$0.0074,980
Broshy EranDirector05/19/2025AADirectCOM10,649$0.00$0.0091,204
Grant Jeremy TDirector05/19/2025AADirectCOM10,649$0.00$0.0032,954
Gray SusannahDirector05/19/2025AADirectCOM10,649$0.00$0.0042,137
Mitchell Dean JDirector05/19/2025AADirectCOM10,649$0.00$0.0091,204
O'Connor DonalDirector05/19/2025AADirectCOM10,649$0.00$0.0074,204
Pakianathan DeepikaDirector05/19/2025AADirectCOM10,649$0.00$0.0058,065
Miller AineSVP, DEV & HEAD OF IRE OFFICE05/19/2025AADirectCOM10,430$0.00$0.00224,691
1   2  3  4  Next Last  You are at page 1 of 4 pages
Transaction Type Key
First letter: A = Acquired, D = Disposed
Second letter:
A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust 		Export Table Data to Excel Send to Excel